Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
This study is currently recruiting participants.
Verified by Spectrum Pharmaceuticals, Inc, May 2009
First Received: January 11, 2008   Last Updated: May 20, 2009   History of Changes
Sponsor: Spectrum Pharmaceuticals, Inc
Information provided by: Spectrum Pharmaceuticals, Inc
ClinicalTrials.gov Identifier: NCT00598806
  Purpose

This is a multicenter, randomized, placebo-controlled, double-blind, study. Following TUR-BT, eligible patients will be randomized to receive either intravesical EOquin® (Apaziquone) or matching placebo instilled within 6 hours of surgery. Patients will be seen for a postoperative follow-up exam 21±10 days after the TUR. At this time, the pathology report will be reviewed. If the histology of the patient's tumor is Ta, G1-G2 (low grade [WHO/ISUP classification]), then the patient will receive no further treatment and will be observed cystoscopically every three months through year two for tumor recurrence and progression. If the histology of the patient's tumor is other than Ta, G1-G2 (low grade [WHO/ISUP classification]), then the patient will receive further treatment in accordance with current treatment guidelines, following which the patient will be followed up cystoscopically every three months through year two for tumor recurrence and progression.

The primary endpoint is to evaluate the recurrence rate at 2 years in randomized patients with tumor histology Ta, G1-G2 who receive TUR-BT plus EOquin® versus those who receive TUR-BT plus placebo.


Condition Intervention Phase
Bladder Cancer
Drug: EOquin® (Apaziquone)
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer

Resource links provided by NLM:


Further study details as provided by Spectrum Pharmaceuticals, Inc:

Primary Outcome Measures:
  • To evaluate the recurrence rate at 2 years in randomized patients with tumor histology Ta, G1-G2 who receive TUR-BT plus EOquin® versus those who receive TUR-BT plus placebo. [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To evaluate time to first recurrence in patients with tumor histology Ta, G1-G2 who receive TUR-BT plus EOquin® versus those who receive TUR-BT plus placebo. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • To evaluate progression to higher stage or grade, number of recurrences per patient, disease free interval, disease free survival and overall survival. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • To assess the safety of EOquin instilled into the bladder in the early postoperative period. [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 800
Study Start Date: September 2007
Estimated Study Completion Date: April 2010
Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Placebo Comparator
Placebo
Drug: EOquin® (Apaziquone)
4mg in 40 mL for intravesical instillation
2: Experimental
EOquin® (Apaziquone)
Drug: EOquin® (Apaziquone)
4mg in 40 mL for intravesical instillation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

All of the following questions must be answered "Yes" in order for the patient to participate in the study.

  1. Has the patient given written informed consent?
  2. Is the patient at least 18 years old?
  3. Does the patient have transitional cell carcinoma of the bladder with clinically apparent tumor Ta, grade G1-G2?
  4. If the patient is a female of childbearing potential, is she using an acceptable/effective method of contraception?
  5. If the patient is a female of childbearing potential, has she had a negative serum pregnancy test within the past 14 days?
  6. Is the patient willing and able to abide by the protocol?

Exclusion Criteria:

All of the following questions must be answered "No" in order for the patient to participate in the study.

  1. Does the patient have more than 5 bladder tumors?
  2. Does any single bladder tumor exceed 3.5 cm in diameter?
  3. Does the patient have a single, primary bladder tumor <0.5 cm and has no previous diagnosis of bladder cancer?
  4. Has the patient ever received EOquin(r)?
  5. Does the patient have, or has the patient ever had, any bladder tumor known to be other than tumor Ta or grade G1 or G2 (low grade [WHO/ISUP classification])?
  6. Does the patient have, or has the patient ever had any bladder tumor with histology other than transitional cell carcinoma?
  7. Does the patient have, or has the patient ever had, CIS?
  8. Does the patient have an active urinary tract infection?
  9. Does the patient have a bleeding disorder or a screening platelet count < 100 x 109/L?
  10. Does the patient have any unstable medical condition that would make it unsafe for him/her to undergo TUR-BT under general or spinal anesthesia?
  11. Does the patient have screening hemoglobin < 10 mg/dL, a screening absolute neutrophil count < 1.5 x 109/L?
  12. Does the patient have a known immunodeficiency disorder?
  13. Has the patient received any investigational treatment within the past 30 days?
  14. Is the patient breast feeding?
  15. Does the patient have a history of interstitial cystitis?
  16. Does the patient have a history of allergy to red color food dye?
  17. Has the patient had transitional cell carcinoma of the bladder within the past 4 months?
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00598806

Contacts
Contact: Shanta Chawla, MD (949) 788-6700 ext 257 schawla@spectrumpharm.com
Contact: Deborah Robbins (949) 788-6700 ext 235 drobbins@spectrumpharm.com

  Hide Study Locations
Locations
United States, California
Advanced Urology Medical Center Clinical Trials Recruiting
Anaheim, California, United States, 92801
Contact: Vera Martinez     714-776-2030        
Principal Investigator: Alfred Sidhom, MD            
United States, Florida
Hal J. Bashein, D.O. Recruiting
West Palm Beach, Florida, United States, 33407
Contact: Sara Fonseca     561-848-8700        
Principal Investigator: Hal J Bashein, DO            
United States, Georgia
Urology Enterprises Recruiting
Marietta, Georgia, United States, 30060
Contact: Becky Hippensteel     678-594-0108        
Principal Investigator: Ronald Roper, MD            
North Fulton Urology Recruiting
Roswell, Georgia, United States, 30076
Contact: Cindy Nelson, RN     770-752-8632        
Principal Investigator: Lewis Kriteman, MD            
United States, Illinois
Hines VA Hospital Recruiting
Hines, Illinois, United States, 60141
Contact: Thomas P. Koppes, RN     708-202-8387 ext 21786        
Principal Investigator: Jeff Branch, MD            
United States, Louisiana
The Urology Center Recruiting
Slidell, Louisiana, United States, 70458
Contact: Gala Daftary     985-649-6660        
Principal Investigator: Mahmoud Daftary, MD            
United States, Maryland
Chesapeake Urology Research Associates Not yet recruiting
Towson, Maryland, United States, 21204
Contact: Debra Robertson     410-825-6310 ext 163        
Principal Investigator: Ronald Tutrone, MD            
Chesapeake Urology Research Associates Not yet recruiting
Baltimore, Maryland, United States, 21237
Contact: Dorothy Richardson     410-803-0089        
Contact: Janette Class, RN     410-391-6131        
Principal Investigator: William Dowling, MD            
United States, Michigan
William Beaumont Hospital Recruiting
Royal Oak, Michigan, United States, 48073
Contact: Deborah Hasenau     248-551-1225        
Principal Investigator: Ronald Rubenstein, MD            
United States, New Jersey
PharmaTrials, Inc. - Somerset Ambulatory Surgical Center Recruiting
Hillsborough, New Jersey, United States, 08844
Contact: Malgorzata "Gosha" Stecko-Brzozowski, RN     908-359-2099        
Principal Investigator: Joel M. Fischer, MD            
PharmaTrials, Inc. - Male & Female Urology Recruiting
Hillsborough, New Jersey, United States, 08844
Contact: Malgorzata "Gosha" Stecko-Brzozowski, RN     908-359-2099        
Principal Investigator: Richard Maggio, MD            
PharmaTrials, Inc. Recruiting
Hillsborough, New Jersey, United States, 08844
Contact: Monika Tiemeyer, RN     908-359-2099        
Principal Investigator: Anthony Catanese, MD            
United States, New York
North Shore - LIJ Health System - The Arthur Smith Institute for Urology Recruiting
New Hyde Park, New York, United States, 11040
Contact: Dolorita de Jesus     516-734-8515        
Principal Investigator: Gary Weiss, MD            
Urology Associates, PC Recruiting
Manhasset, New York, United States, 11030
Contact: Tiffanie Pederson     516-320-7047        
Principal Investigator: Christopher Johnson, MD            
Medical & Clinical Research Associates, LLC Recruiting
Bay Shore, New York, United States, 11706
Contact: Joann Hallgren, RN     631-665-3734        
Principal Investigator: Daniel C. Kim, MD            
United States, North Carolina
Piedmont Medical Research Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact: Megan Fox     336-768-8062        
Principal Investigator: David O. Cook, MD            
Alliance Urology Specialists Recruiting
Greensboro, North Carolina, United States, 27403
Contact: Pattie Edwards     336-274-1114 ext 5328        
Contact: Karen Michael, RN     336-274-1114 ext 5328        
Principal Investigator: John J. Wrenn, MD            
United States, Pennsylvania
Center for Urologic Care Recruiting
Bryn Mawr, Pennsylvania, United States, 19010
Contact: Carol Wenger, RN     610-525-2515        
Principal Investigator: Guy T. Bernstein, MD            
United States, South Carolina
Medical University of South Carolina, Dept. of Urology Recruiting
Charleston, South Carolina, United States, 29425
Contact: Jessica Jenkins     843-876-0630        
Principal Investigator: Stephen Savage, MD            
United States, Texas
Urology Associates of South Texas Recruiting
McAllen, Texas, United States, 78503
Contact: Marissa Leal     956-429-0357        
Principal Investigator: Henry E. Ruiz, MD            
United States, Utah
Salt Lake Research Recruiting
Salt Lake City, Utah, United States, 84107
Contact: Rosa Vargas     801-288-9778        
Principal Investigator: Stephen Richardson, MD            
United States, Virginia
Adult and Pediatric Urologists Recruiting
Alexandria, Virginia, United States, 22304
Contact: Pamela Harrison     703-370-2132        
Principal Investigator: George Tawill, MD            
Canada
Centre hospitalier universitaire de Quebec Recruiting
Quebec, Canada, G1R3S3
Contact: Denyse L'Héreault     418-691-5050        
Principal Investigator: Yves Fradet, MD            
Canada, Alberta
Prostate Cancer Institute Recruiting
Calgary, Alberta, Canada, T2V4R6
Contact: Madalyn Vachon, RN     403-301-2437        
Principal Investigator: Jay Lee, MD            
Canada, British Columbia
Lintor Medical, Inc. Recruiting
North Vancouver, British Columbia, Canada, V7L2P7
Contact: Maureen McGrath     604-765-9287        
Principal Investigator: Victor Chow, MD            
G. Steinhoff Clinical Research Recruiting
Victoria, British Columbia, Canada, V8V3N1
Contact: Catherine Douglas     250-388-0840        
Principal Investigator: Gary Steinhoff, MD            
Andreou Research Recruiting
Surrey, British Columbia, Canada, V3V1N1
Contact: Wendy Largy     604-583-2271        
Principal Investigator: Cal Andreou, MD            
Southern Interior Medical Research Corporation Recruiting
Kelowna, British Columbia, Canada, V1Y2H4
Contact: Joe Husch     250-764-1949        
Principal Investigator: Thomas J. Kinhan, MD            
Can-Med Clinical Research, Inc Recruiting
Victoria, British Columbia, Canada, V8T5G1
Contact: Renza Brown     250-370-2606        
Principal Investigator: Peter Pommerville, MD            
Canada, Nova Scotia
Queen Elizabeth II Health Sciences Centre Recruiting
Halifax, Nova Scotia, Canada, B3H2Y9
Contact: Susan Winch     902-473-6604        
Principal Investigator: Ricardo A. Rendon, MD            
Canada, Ontario
Sunnybrook Health Sciences Centre Recruiting
Toronto, Ontario, Canada, M4N3M5
Contact: Irene McNeal     416-480-6100 ext 2431        
Principal Investigator: Laurence Klotz, MD            
Urotec Recruiting
Oshawa, Ontario, Canada, L1H7K4
Contact: Connie Martinell     905-721-4300 ext 5353        
Principal Investigator: Arun Mathur, MD            
Brantford Urology Research Recruiting
Brantford, Ontario, Canada, N3R4N3
Contact: Nora Leung     519-753-9221        
Principal Investigator: Wilson Leung, MD            
The Male/Female Health and Research Center - Royal Court Medical Centre Recruiting
Barrie, Ontario, Canada, L4M7G1
Contact: Karen Hill     705-727-0551        
Contact: Judy Cannon     705-739-7016        
Principal Investigator: Joseph Zadra, MD            
London Health Sciences Centre Recruiting
London, Ontario, Canada, N6A5W9
Contact: Wendy Shoff, RN     519-685-8500 ext 57350        
Contact: Catherine Hildebrand     519-685-8500 ext 53535        
Principal Investigator: Joseph Chin, MD            
Saint Joseph Health Center Recruiting
Toronto, Ontario, Canada, M6S4W4
Contact: Kusum Sharma     416-767-0995        
Principal Investigator: Umesh Jain, MD            
Urology Resource Centre Recruiting
Burlington, Ontario, Canada, L7S1V2
Contact: Jane Love     905-681-9300        
Principal Investigator: William Love, MD            
University Health Network Princess Margaret Hospital Recruiting
Toronto, Ontario, Canada, M5G2M9
Contact: Kelly Caetano     416-946-4501 ext 3141        
Principal Investigator: Neil Fleshner, MD            
Dr. Bernard Goldfarb Recruiting
North Bay, Ontario, Canada, P1B7K8
Contact: Terri Moreau     705-482-1063        
Principal Investigator: Bernard Goldfarb, MD            
The Fe/Male Health Centre Recruiting
Oakville, Ontario, Canada, L6H3P1
Contact: Djordje Adanja     905-338-3130 ext 225        
Contact: Rupi Dhaliwal     905-338-3130 ext 226        
Principal Investigator: Richard Casey, MD            
The Ottawa Hospital - Civic Recruiting
Ottawa, Ontario, Canada, K1Y4E9
Contact: Peggy Graham     613-798-5555 ext 17594        
Principal Investigator: Christopher Morash, MD            
Mor Urology, Inc. Recruiting
Newmarket, Ontario, Canada, L3X1W1
Contact: Diane Stone     905-853-7468        
Contact: Donna Liquornik     905-853-7468        
Principal Investigator: Morrie Liquornik, MD            
AGT Research Recruiting
Scarborough, Ontario, Canada, M1P2T7
Contact: Beverley Taylor     416-439-8913        
Principal Investigator: Allan Toguri, MD            
Urology & Male Infertility Recruiting
Scarborough, Ontario, Canada, M1S4V5
Contact: Polina Schvarts     416-754-1019        
Principal Investigator: Allan Abramovitch, MD            
Urology Associates, Urologic Medical Research Recruiting
Kitchener, Ontario, Canada, N2N2B9
Contact: Linda Morriss     519-578-0470 ext 3        
Principal Investigator: Russell B. Egerdie, MD            
Kingston General Hospital / Queen's University Recruiting
Kingston, Ontario, Canada, K7L3J7
Contact: Laurel Emerson     613-548-6033        
Principal Investigator: Robert D. Siemens, MD            
Toronto East General Hospital Recruiting
Toronto, Ontario, Canada, M4C5T2
Contact: Sandra Brazel     416-233-7231        
Principal Investigator: Rajiv K. Singal, MD            
Mahoney Medicine Professional Corporation Recruiting
Ottawa, Ontario, Canada, K1H8L6
Contact: Tammy Knight     613-737-8659        
Principal Investigator: John Mahoney, MD            
The Male Health Centre Recruiting
Toronto, Ontario, Canada, M6A3B5
Contact: Shelley Burton     416-256-9606        
Principal Investigator: Jack Barkin, MD            
Orillia Urology Associates Recruiting
Orillia, Ontario, Canada, L3V7V1
Contact: Kurt Fountain     705-325-8004        
Principal Investigator: Ben Okafo, MD            
Stanley Flax Medical Professional Corporation Recruiting
North York, Ontario, Canada, M3B3S6
Contact: Tracy Hobbins     416-449-8551        
Principal Investigator: Stanley Flax, MD            
G. Kenneth Jansz Medicine Professional Corporation Recruiting
Burlington, Ontario, Canada, L7N3V2
Contact: Linda Hager     905-681-9149        
Principal Investigator: Ken Jansz, MD            
ADA Medical Ltd. Recruiting
Peterborough, Ontario, Canada, K9J7B3
Contact: Michelle Thornley, RN     416-617-6338        
Principal Investigator: Mohamed El Harram, MD            
Canada, Quebec
UroLaval Recruiting
Laval, Quebec, Canada, H7G2E6
Contact: Jane Bell     450-972-2474        
Principal Investigator: Jean Simrad, MD            
McGill Urology Associates Recruiting
Montreal, Quebec, Canada, H3G1A4
Contact: Wendella Hamilton     514-735-9981 ext 105        
Principal Investigator: Wassim Kassouf, MD            
Centre Hospitalier Universitaire de Sherbrooke Recruiting
Sherbrooke, Quebec, Canada, J1H5N4
Contact: Elsie Morneau     819-346-1110 ext 12827        
Principal Investigator: Michel Carmel, MD            
Ultra-Med, Inc. Recruiting
Pointe Clare, Quebec, Canada, H9R4S3
Contact: Sylvia Boudreau     514-426-8008        
Principal Investigator: David Eiley, MD            
Poland
Fundacja "Urologia", Międzyleski Szpital Specjalistyczny w Warszawie Not yet recruiting
Warszawa, Poland, 04-749
Contact: Andrzej Borówka, Prof. dr hab. n. med.     +48 022 815 68 61        
Principal Investigator: Andrzej Borówka, Prof. dr hab. n. med.            
Szpital Kliniczny Dzieciątka Jezus - Centrum Leczenia Obrażeń Recruiting
Warszawa, Poland, 02-005
Contact: Andrzej Borkowski, Prof. dr hab. n. med.     +48 022 502 21 48        
Principal Investigator: Andrzej Borkowski, Prof. dr hab. n. med.            
Centrum Onkologii im. Marii Skodowskiej-Curie Not yet recruiting
Warszawa, Poland, 02-781
Contact: Tomasz Demkow, Prof. dr hab. n. med.     +48 022 546 30 53        
Principal Investigator: Tomasz Demkow, Prof. dr hab. n. med.            
Centrum Medycznego Kształcenia Podyplomowego, Samodzielny Publiczny Szpital Kliniczny im. Prof. W. Orłowskiego Not yet recruiting
Warszawa, Poland, 00-416
Contact: Wojciech Pypno, Dr hab. n. med.     48 022 621 71 78        
Principal Investigator: Wojciech Pypno, Dr hab. n. med.            
Szpital Specjalistyczny w Kościerzynie Not yet recruiting
Kościerzyna, Poland, 83-400
Contact: Krzysztof Szkarłat, Dr n. med.     +48 058 686 86 59        
Principal Investigator: Krzysztof Szkarłat, Dr n. med.            
Szpital Kolejowy im. Dr med.. Włodzimierza Roeflera w Pruszkowie Not yet recruiting
Pruszków, Poland, 05-800
Contact: Andrzej Stokłosa, Dr n. med.     +48 022 825 44 38        
Principal Investigator: Andrzej Stokłosa, Dr n. med.            
Wojewódzki Szpital Specjalistyczny W Siedlcach Not yet recruiting
Siedlce, Poland, 08-110
Contact: Tadeusz Dmowski, Dr n. med.     48 025 640 32 98        
Principal Investigator: Tadeusz Dmowski, Dr n. med.            
Uniwersytecki Szpital Kliniczny nr 2 Wojskowej Akademii Medycznej Uniwersytetu Medycznego w Łodzi - Centralny Szpital Weteranów Not yet recruiting
Łódź, Poland, 90-549
Contact: Marek Sosnowski, Prof. dr hab. n. med.     +48 042 636 82 14        
Principal Investigator: Marek Sosnowski, Prof. dr hab. n. med.            
Samodzielny Publiczny Zakład Opieki Zdrowotnej w Pabianicach Not yet recruiting
Pabianice, Poland, 95-200
Contact: Grzegorz Krzyżanowski, Dr n. med.     +48 042 225 37 76        
Principal Investigator: Grzegorz Krzyżanowski, Dr n. med.            
Uniwersytecki Szpital Kliniczny Not yet recruiting
Białystok, Poland, 15-276
Contact: Barbara Darewicz, Prof. dr hab. n. med.            
Principal Investigator: Barbara Darewicz, Prof. dr hab. n. med.            
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie Not yet recruiting
Lublin, Poland, 20-954
Contact: Krzysztof Bar, Prof. dr hab. n. med.            
Principal Investigator: Krzysztof Bar, Prof. dr hab. n. med.            
Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki Zdrowotnej Not yet recruiting
Kielce, Poland, 25-734
Contact: Piotr Chłosta, Dr n. med.     +48 041 367 47 73        
Principal Investigator: Piotr Chłosta, Dr n. med.            
Niepubliczny Zakład Opieki Zdrowotnej "Racławicka" Not yet recruiting
Kraków, Poland, 30-017
Contact: Marek Wyczółkowski, Dr hab. n. med.     +48 012 646 82 49        
Principal Investigator: Marek Wyczółkowski, Dr hab. n. med.            
Szpital Miejski im. Prof. E. Michałowskiego Not yet recruiting
Katowice, Poland, 40-073
Contact: Wiesław Duda, Dr n. med.     +48 032 251 54 36        
Principal Investigator: Wiesław Duda, Dr n. med.            
Szpital Wojewódzki w Bielsku-Białej Not yet recruiting
Bielsko-Biała, Poland, 43-316
Contact: Krzysztof Pliszek, Dr n. med.     +48 033 810 23 54        
Principal Investigator: Krzysztof Pliszek, Dr n. med.            
Samodzielny Publiczny Zakład Opieki Zdrowotnej, Wojewódzki Szpital Specjalistyczny nr 3 Recruiting
Rybnik, Poland, 44-200
Contact: Jacek Węglorz, Dr n. med.     +48 032 429 15 79        
Principal Investigator: Jacek Węglorz, Dr n. med.            
Akademicki Szpital Kliniczny im Jana Mikulicza-Radeckiego we Wrocławiu Not yet recruiting
Wrocław, Poland, 50-556
Contact: Romuald Zdrojowy, Prof. dr hab. n. med.     +48 071 359 21 61        
Principal Investigator: Romuald Zdrojowy, Prof. dr hab. n. med.            
Wojewódzki Szpital Specjalistyczny we Wrocławiu, Ośrodek Badawczo Rozwojowy Not yet recruiting
Wrocław, Poland, 51-124
Contact: Jerzy Sokołowski, Dr n. med.     +48 071 327 03 15        
Principal Investigator: Jerzy Sokołowski, Dr n. med.            
Zakład Opieki Zdrowotnej Poznań - Stare Miasto Not yet recruiting
Poznań, Poland, 61-285
Contact: Paweł Kalwas, Dr n. med.     +48 061 873 92 37        
Principal Investigator: Paweł Kalwas, Dr n. med.            
Publiczny Specjalistyczny Zakład Opieki Zdrowotnej w Inowrocławiu Not yet recruiting
Inowrocław, Poland, 88-100
Contact: Szymon Kwiatkowski, Dr n. med.     +48 052 354 55 68        
Principal Investigator: Szymon Kwiatkowski, Dr n. med.            
Pomorska Akademia Medyczna Not yet recruiting
Szczecin, Poland, 70-111
Contact: Andrzej Sikorski, Prof. dr hab. n. med.     +48 091 466 11 00        
Principal Investigator: Andrzej Sikorski, Prof. dr hab. n. med.            
Wojewódzki Szpital Specjalistyczny im Janusza Korczaka Not yet recruiting
Słupsk, Poland, 76-200
Contact: Jacek Ołubiec, Dr n. med.     +48 059 841 34 15        
Principal Investigator: Jacek Ołubiec, Dr n. med.            
Akademickie Centrum Kliniczne - Szpital Akademii Medycznej w Gdańsku Not yet recruiting
Gdańsk, Poland, 80-402
Contact: Kazimierz Krajka, Prof. dr hab. n. med.     +48 058 349 38 24        
Principal Investigator: Kazimierz Krajka, Prof. dr hab. n. med.            
Wojskowy Instytut Medyczny, Centralny Szpital Kliniczny MON Not yet recruiting
Warszawa, Poland, 00-909
Contact: Henryk Zieliński, Dr hab. n. med.     +48 022 681 63 19        
Principal Investigator: Henryk Zieliński, Dr hab. n. med.            
Sponsors and Collaborators
Spectrum Pharmaceuticals, Inc
  More Information

No publications provided

Responsible Party: Spectrum Pharmaceuticals ( Spectrum Pharmaceuticals )
Study ID Numbers: SPI-612
Study First Received: January 11, 2008
Last Updated: May 20, 2009
ClinicalTrials.gov Identifier: NCT00598806     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Spectrum Pharmaceuticals, Inc:
Noninvasive Bladder Cancer

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Urologic Diseases
Antineoplastic Agents
Therapeutic Uses
Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urogenital Neoplasms
Urologic Neoplasms
EO 9
Pharmacologic Actions

ClinicalTrials.gov processed this record on November 22, 2009